The strict customs scrutiny and non-clearance of imports from China has hit the Indian pharmaceutical sector amid the COVID-19 pandemic, making industry representatives reach out to the government.
The strict customs scrutiny and non-clearance of imports from China has hit the Indian pharmaceutical sector amid the COVID-19 pandemic, making industry representatives reach out to the government.